Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback